Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. is positioned for significant growth potential through 2026 and 2027, driven by an anticipated increase in acquisition activity, with an expected additional $600 million in 2026. The company is benefiting from strong performance in its Trilogy-operated units, which are experiencing healthy growth due to favorable industry trends and an improved skill mix, projected to yield a two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for SHOP. With a superior cost of capital since late 2024, American Healthcare REIT is in a strong position to capitalize on external growth opportunities, enhancing its ability to deploy capital efficiently.

Bears say

American Healthcare REIT faces a negative outlook primarily due to the significant risks associated with its tenant performance, particularly in regions experiencing economic challenges or regulatory changes that could adversely affect rental income. The reliance on skilled nursing facilities for nearly half of the company's net operating income (NOI) introduces heightened volatility, making the REIT vulnerable to fluctuations in both tenant financial health and broader market conditions. Additionally, potential headwinds related to capital market volatility, rising construction costs, and increased competition may hinder the company’s ability to meet organic NOI growth expectations, further impacting its earnings potential.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.